Wealth Enhancement Advisory Services, LLC Lyell Immunopharma, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 12,596 shares of LYEL stock, worth $6,046. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,596Holding current value
$6,046% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LYEL
# of Institutions
110Shares Held
172MCall Options Held
7.7KPut Options Held
15.3K-
Mwg Management Ltd. Washington, DC20.2MShares$9.68 Million17.35% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$7.25 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$7.25 Million14.08% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$6.48 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA11.9MShares$5.72 Million1.63% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $119M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...